Déjà Vu: CBER Director’s Intervention Saves Sarepta’s Elevidys Again

 
• By Bridget Silverman
Boy in wheelchair
FDA expanded use of Elevidys to non-ambulatory DMD patients under accelerated approval. • Source: Shutterstock

More from Approvals

More from Product Reviews